World Diabetes Day is November 14.
Treating diabetes is a family affair.
Globally, more than 425 million people live with diabetes.1 That means more than 425 million families live with diabetes, too. The disease often takes a financial and emotional toll on everyone involved because successful treatment often requires frequent access to a variety of healthcare professionals. Because early detection is key to preventing complications and improving outcomes, World Diabetes Day is dedicated to making sure families and caregivers alike know the signs, symptoms and risk factors of the this rapidly growing epidemic.
Family support is known to have a substantial impact on improving health outcomes.2
As a healthcare provider, you simply can’t be there all the time for your patients — so it’s critical you get the most from every office visit. That’s why point of care testing is so important. When you can get accurate HbA1c test results at the point of care, there’s no need for follow-up calls or appointments — you have all the information you need while the patient is still in the exam room. Being able to test, diagnose and treat in the moment been proven to improve the patient’s motivation, attitude, and even their relationship with their clinician.4
Another important tactic is to make sure each patient’s support network has the information and resources they need. Consider lifestyle counseling and group education with regular and appropriate follow-up.
After all, families have a positive influence in maintaining lifestyle changes and diabetes self-management, from managing diet and medications to checking blood glucose levels. The more these families know about the link between diabetes and a healthier lifestyle, the more empowered they can be to help.
Rapid diagnostic solutions to help you fight diabetes
When left undiagnosed or untreated, diabetes can often lead to a variety of other health issues, including heart disease, stroke, kidney damage, and nerve damage.3 The good news is, these complications can be prevented through treatment. Early detection can lead to the lifestyle changes needed to prevent or significantly delay the onset of the disease.
Patient non-compliance and missed appointments lead to poor testing and therapy adherence.5
Accurate, actionable results from the leader in point-of-care lipid testing.
The CLIA-waived Alere Cholestech LDX® System helps monitor your at-risk patients. Engineered for confidence, this analyzer provides accurate, actionable, and readily accessible results for point-of-care lipid profile, cholesterol, and glucose testing.
Your First Point-of-Care.
NycoCard™ READER II is a multi assay instrument for point-of-care testing. With NycoCard READER II, healthcare professionals in doctors’ offices, clinics and hospitals will obtain accurate, quantitative results within minutes. Available test include NycoCard™ HbA1c and NycoCard™ U-Albumin.
Your Practice – With More Success
What if you could help alleviate the burden of diabetes management for patients, families and you? Clincal Lab Product’sarticle on “The Need for Point-of-Care HbA1c Testing for Diabetes” shows the benefits of POC testing for patients and practices.